BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32038810)

  • 1. Subcutaneous Four-Week Repeated Dose Toxicity Studies of Rice Cell-Derived Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Rats.
    Ji JE; Lee JM; Choi JM; Choi YH; Kim EK; Chu SJ; Kim SK; Ahn KH; Lee DH; Kim HH; Han K; Kim DK
    Toxicol Res; 2008 Dec; 24(4):315-320. PubMed ID: 32038810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
    Mayer P; Werner FJ; Lam C; Besemer J
    Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pichia pastoris versus Saccharomyces cerevisiae: a case study on the recombinant production of human granulocyte-macrophage colony-stimulating factor.
    Tran AM; Nguyen TT; Nguyen CT; Huynh-Thi XM; Nguyen CT; Trinh MT; Tran LT; Cartwright SP; Bill RM; Tran-Van H
    BMC Res Notes; 2017 Apr; 10(1):148. PubMed ID: 28376863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of recombinant human granulocyte-macrophage colony stimulating factor on in vitro cord blood granulocyte function.
    Frenck RW; Buescher ES; Vadhan-Raj S
    Pediatr Res; 1989 Jul; 26(1):43-8. PubMed ID: 2549492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human granulocyte-macrophage colony-stimulating factor (hGM-CSF)-dependent in vitro and in vivo proliferation and differentiation of all hematopoietic progenitor cells in hGM-CSF receptor transgenic mice.
    Nishijima I; Watanabe S; Nakahata T; Arai K
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S79-86. PubMed ID: 9440551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity.
    Sullivan GW; Carper HT; Mandell GL
    Blood; 1993 Apr; 81(7):1863-70. PubMed ID: 7681704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human granulocyte macrophage-colony stimulating factor in long-term marrow cultures from patients with aplastic anemia.
    Martínez-Jaramillo G; Gómez-Morales E; Mayani H
    Am J Hematol; 1999 Jun; 61(2):107-14. PubMed ID: 10367789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down-regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells.
    Du Z; Li Y; Xia H; Irani AM; Schwartz LB
    J Immunol; 1997 Jul; 159(2):838-45. PubMed ID: 9218602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor.
    Lieschke GJ; Cebon J; Morstyn G
    Blood; 1989 Dec; 74(8):2634-43. PubMed ID: 2684297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and purification of biologically active human granulocyte-macrophage colony stimulating factor (hGM-CSF) using silkworm-baculovirus expression vector system.
    Kinoshita Y; Xu J; Masuda A; Minamihata K; Kamiya N; Mon H; Fujita R; Kusakabe T; Lee JM
    Protein Expr Purif; 2019 Jul; 159():69-74. PubMed ID: 30917920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML)].
    Tanosaki R; Okamoto S; Takahashi S; Inoue T; Kikuno K; Aoki Y; Takada M; Irie S; Shimane M; Tojo A
    Rinsho Ketsueki; 1993 Aug; 34(8):946-51. PubMed ID: 8105115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor.
    Schuening FG; Storb R; Goehle S; Nash R; Graham TC; Appelbaum FR; Hackman R; Sandmaier BM; Urdal DL
    Exp Hematol; 1989 Sep; 17(8):889-94. PubMed ID: 2670596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic and lymphopoietic responses in human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor transgenic mice injected with human GM-CSF.
    Nishijima I; Nakahata T; Watanabe S; Tsuji K; Tanaka I; Hirabayashi Y; Inoue T; Arai K
    Blood; 1997 Aug; 90(3):1031-8. PubMed ID: 9242533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of nerve growth factor and granulocyte-macrophage colony-stimulating factor on human basophilic cell differentiation.
    Tsuda T; Wong D; Dolovich J; Bienenstock J; Marshall J; Denburg JA
    Blood; 1991 Mar; 77(5):971-9. PubMed ID: 1995103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
    Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
    Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rice cell-derived human granulocyte-macrophage colony-stimulating factor on 5-fluorouracil-induced mucositis in hamsters.
    Won JH; Ji JE; Ahn KH; Kim SK; Choi JM; Ha HC; Kim HM; Yun CK; Han K; Kim DK
    Biol Pharm Bull; 2013; 36(3):425-31. PubMed ID: 23449328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study.
    Ganser A; Lindemann A; Ottmann OG; Seipelt G; Hess U; Geissler G; Kanz L; Frisch J; Schulz G; Herrmann F
    Blood; 1992 May; 79(10):2583-91. PubMed ID: 1586711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
    Cannistra SA; DiCarlo J; Groshek P; Kanakura Y; Berg D; Mayer RJ; Griffin JD
    Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.